Updated
Updated · Ars Technica · Jul 31
Pathogenic Sells 100,000 Copies as Steam Reviews Turn Overwhelmingly Positive
Updated
Updated · Ars Technica · Jul 31

Pathogenic Sells 100,000 Copies as Steam Reviews Turn Overwhelmingly Positive

1 articles · Updated · Ars Technica · Jul 31

Summary

  • Pathogenic has quickly reached 100,000 sales on Steam, with player feedback climbing to an “overwhelmingly positive” rating in the weeks after launch.
  • Aberrant Labs’ roguelite twin-stick shooter stands out by casting players as a pathogen invading a lab assistant’s body after a dropped vial and ankle cut.
  • Runs progress through the skin, intestines, liver, stomach, lungs and heart, with boss fights and build upgrades driving the game’s escalating difficulty.
  • The strong early reception gives the indie release unusual momentum in a crowded action-roguelite market.

Insights

Could playing as a mutating pathogen in this indie hit secretly be the ultimate crash course in human immunology?
How did a two-person team turn a deadly biological invasion into Steam's latest viral gaming obsession?